Atlas Capital Advisors LLC Intellia Therapeutics, Inc. Transaction History

Atlas Capital Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$53.92 - $71.7 $9,004 - $11,973	167 New	167 $9.35 Million
Q2 2022 Aug 16, 2022	SELL	$38.49 - $76.21 $6,427 - $12,727	-167 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$100.76 - $138.36 $4,534 - $6,226	45 Added 36.89%	167 $19.7 Million
Q3 2021 Oct 28, 2021	BUY	$132.37 - $176.78 $16,149 - $21,567	122 New	122 $16,000

344

98.4M

784K

713K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $734M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Atlas Capital Advisors LLC with notifications on news.